Merck & Co., Inc., et al. Withdraw FDA Approval for 39 New Drug Applications, 13 Abbreviated Antibiotic Applications, and 46 Abbreviated New Drug Applications

Summary

The US Food and Drug Administration (FDA) has withdrawn approval for 39 new drug applications, 13 abbreviated antibiotic applications, and 46 abbreviated new drug applications, following notifications from the applicants that the corresponding drug products are no longer commercially available.